PlainVisa
2026 data Public-data reference Official source

Glenmark Pharmaceuticals, Inc. USA

A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.

DOL LCA filings
18
DOL-certified
94.4%
Median offered wage
$160,695

Mahwah, NJ NAICS: 424210

Glenmark Pharmaceuticals, Inc. USA, by the LCA numbers

U.S. Department of Labor's OFLC discloses 18 Labor Condition Application filings naming Glenmark Pharmaceuticals, Inc. USA from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs

How many H-1B petitions has USCIS approved for Glenmark Pharmaceuticals, Inc. USA?

Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 28 H-1B petitions naming Glenmark Pharmaceuticals, Inc. USA through FY2024, and approved the large majority of them: 96.4% approved (27 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.

The verdict

Glenmark Pharmaceuticals, Inc. USA is listed in 18 DOL LCA filings, more filings than 90% of employer filers in this extract. DOL certified 94.4% of those LCAs; the median listed offered wage is $160,695. This is not a USCIS approval, hiring, or sponsorship ranking.

18
DOL LCA filings, FY2023–FY2026
94.4%
DOL-certified
$160,695
median offered wage
Top 10%
of employer filers by volume

According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in Mahwah, NJ.

Saved on this device only, no account, no email. Open saved list Follow this profile's data updates Updates when the published DOL data vintage changes; this is a feed, not an alert service.

Glenmark Pharmaceuticals, Inc. USA vs all U.S. employer filers by LCA volume

Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)

18 12320th of 122824 higher than 110,504 of 122,824 employer filers

Employer filers, banded by disclosed H-1B LCA filing count

Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source U.S. Department of Labor OFLC · FY2023–FY2026

LCA filing shape · Glenmark Pharmaceuticals, Inc. USA

Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.

Offered-wage span on file: $105,000$315,000 .

Title concentration

  • Validation Specialist 4 · 22.2% · $108,105
  • Manufacturing, Science & Technology (MSAT) Manager 3 · 16.7% · $137,726
  • Site Quality Head 2 · 11.1% · $315,000
  • Senior Director “ Quality, North America 2 · 11.1% · $210,000
  • Sterile Injectable Supervisor 1 · 5.6% · $105,000

Worksite counties

  • UNION, NC 11 · 91.7%
  • BERGEN, NJ 1 · 8.3%

DOL LCA release change

What changed between the two LCA fiscal years

FY2024 -> FY2025
  • Glenmark Pharmaceuticals, Inc. USA's disclosed H-1B LCA filing count rose from 4 in FY2024 to 10 in FY2025 (+150%).

Arithmetic differences between stored DOL OFLC Labor Condition Application disclosure fiscal years for this employer identity - not a headcount, hire forecast, or cause claim. Role mix can shift between years even when the filing total is flat. Totals group name variants that share the same identity key.

National filing changes Two-year CSV

Above-prevailing wage posture

On 18 LCAs with comparable offered vs prevailing wages, Glenmark Pharmaceuticals, Inc. USA averages about 30.2% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Experienced (Level III) (66.7% of LCA filings).

Certification Rate

94.4%

Moderate DOL cert

Avg. Salary

$160,695

Well above portal avg

Total Workers

18

Small worker count

Wondering how long it takes USCIS to process an H-1B petition for this employer? See current I-129 processing times →

Salary Analysis

Compensation range for H-1B positions at Glenmark Pharmaceuticals, Inc. USA

Minimum
$105,000
Maximum
$315,000
Average Salary
$160,695

Wage vs. DOL Minimum

+30.2%

High vs DOL floor

national avg +17.8%

Typical DOL Wage Level

Experienced (Level III)

66.7% of LCA filings

Full-Time Positions

100%

Primary Worksite County

UNION, NC

61.1% of LCA filings

Top Occupations

Most frequently listed job titles at Glenmark Pharmaceuticals, Inc. USA

Job Title LCA filings Avg. Salary
Validation Specialist 4 $108,105
Manufacturing, Science & Technology (MSAT) Manager 3 $137,726
Site Quality Head 2 $315,000
Senior Director “ Quality, North America 2 $210,000
Sterile Injectable Supervisor 1 $105,000
Senior Validation Specialist 1 $123,058
Senior Research Scientist 1 $125,000
Senior Manager- QC Stability 1 $139,616
Senior MSAT Specialist 1 $111,662
Director of Quality Assurance 1 $192,571
DIRECTOR ENGINEERING & PROJECTS 1 $200,000

Nationwide peers near Glenmark Pharmaceuticals, Inc. USA's 18-LCA band

Cross-state DOL neighbors for Glenmark Pharmaceuticals, Inc. USA - LCA filing-count and offered-wage axes, outside NJ.

Similar LCA filing volume

Nearest cross-state employer filers by LCA filing count (18 here; floor ≥10 LCA filings).

Similar avg offered wage

Cross-state employer filers with a comparable average listed offered wage ($160,695 here).

Frequently Asked Questions

How many H-1B LCA filings list Glenmark Pharmaceuticals, Inc. USA?

Glenmark Pharmaceuticals, Inc. USA is listed in 18 DOL Labor Condition Application filings covering 18 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.

How does Glenmark Pharmaceuticals, Inc. USA's LCA filing volume compare to other employer filers?

Among 122,824 employer filers in the DOL disclosure extract, Glenmark Pharmaceuticals, Inc. USA ranks #11818 by total LCA filing count (18 filings). 110,504 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.

What is the H-1B DOL certification rate for Glenmark Pharmaceuticals, Inc. USA?

Glenmark Pharmaceuticals, Inc. USA has a 94.4% DOL certification rate, with 17 out of 18 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.

What offered wage is listed in LCAs for Glenmark Pharmaceuticals, Inc. USA?

The average offered wage listed in Glenmark Pharmaceuticals, Inc. USA's LCAs is $160,695. Listed wages range from $105,000 to $315,000 and are not verified actual compensation.

What are the most common H-1B job titles at Glenmark Pharmaceuticals, Inc. USA?

The top job titles in Glenmark Pharmaceuticals, Inc. USA's LCA filing records include Validation Specialist, Manufacturing, Science & Technology (MSAT) Manager, Site Quality Head. The most common listed title is Validation Specialist with 4 LCA filings at an average listed offered wage of $108,105. This does not establish actual job openings, hiring, or approved petitions.

Where is Glenmark Pharmaceuticals, Inc. USA located?

Glenmark Pharmaceuticals, Inc. USA is headquartered in Mahwah, NJ. Their H-1B workers are distributed across 2 states, with the most positions in NC, NJ.

Is Glenmark Pharmaceuticals, Inc. USA H-1B dependent?

No, Glenmark Pharmaceuticals, Inc. USA is not classified as H-1B dependent.

How have Glenmark Pharmaceuticals, Inc. USA's listed LCA filings changed over time?

Glenmark Pharmaceuticals, Inc. USA is listed in 2 LCA filings in FY2023 and 2 in FY2026. The average listed offered wage increased from $107,000 to $141,589. This historical filing series does not predict sponsorship, hiring, or visa outcomes.

Data sourced from U.S. Department of Labor LCA disclosure filings. See our methodology for details.

Disclaimer: Informational only, not professional advice.

Read with Glenmark Pharmaceuticals, Inc. USA

ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-SOLID · WAGE-ELITE.

What to do with this profile

Use the DOL LCA record for Glenmark Pharmaceuticals, Inc. USA to compare filing volume and offered wages, not USCIS outcomes.

DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.

Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.